![John Connelly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di John Connelly
Precedenti posizioni note di John Connelly
Società | Posizione | Inizio | Fine |
---|---|---|---|
VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2015 | 01/02/2018 |
AKOUOS | Corporate Officer/Principal | 01/10/2018 | - |
Formazione di John Connelly
University of Vermont | Undergraduate Degree |
Suffolk University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
VOYAGER THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Akouos, Inc.
![]() Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- John Connelly
- Esperienza